Jan 3 (Reuters) - Suven Life Sciences Ltd SUVP.NS
* Suven Life Sciences Ltd says "Suven Life Sciences secures
two (2) product patents in Eurasia and Norway
* Suven Life Sciences Ltd - products out of these inventions
may be out-licensed at various phases of clinical development
like at phase-I or phase-II
* Suven Life Sciences - grant of patents corresponding to
the new chemical entities (NCES) for the treatment of disorders
associated with neurodegenerative diseases
* Suven Life Sciences Ltd says patents are valid through
2032 and 2025 respectively
Source text - (http://bit.ly/2hJiuBA)
Further company coverage: SUVP.NS
((Bangalore.newsroom@thomsonreuters.com;))